BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21083334)

  • 1. Conference Report: DIA/PhRMA workshop on DBS sampling in the pharmaceutical industry: methodology, implementation & best practices.
    Evans CA; Bruce C; Emmons GT; Gallenberg L; Ji QC; Kinter LB; Musvasva E; Wickremsinhe E
    Bioanalysis; 2010 Aug; 2(8):1355-9. PubMed ID: 21083334
    [No Abstract]   [Full Text] [Related]  

  • 2. DBS: a UK (MHRA) regulatory perspective.
    Beharry M
    Bioanalysis; 2010 Aug; 2(8):1363-4. PubMed ID: 21083336
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploring the feasibility of using the DBS technique for metabolite radioprofiling.
    Wang L; Zeng Z; Emmons G
    Bioanalysis; 2010 Aug; 2(8):1365-71. PubMed ID: 21083337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connecting strategies on dried blood spots.
    Abbott R; Smeraglia J; White S; Luedtke S; Brunet L; Thomas E; Globig S; Timmerman P
    Bioanalysis; 2010 Nov; 2(11):1809-16. PubMed ID: 21083488
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
    Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S
    Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.
    Turpin PE; Burnett JE; Goodwin L; Foster A; Barfield M
    Bioanalysis; 2010 Aug; 2(8):1489-99. PubMed ID: 21083349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human DBS sampling with LC-MS/MS for enantioselective determination of metoprolol and its metabolite O-desmethyl metoprolol.
    Liang X; Jiang H; Chen X
    Bioanalysis; 2010 Aug; 2(8):1437-48. PubMed ID: 21083344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs.
    Denniff P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS.
    Youhnovski N; Michon J; Latour S; Mess JN; Bergeron A; Furtado M; Rufiange M; Guibord P; Lefebvre M; Macarthur RB; Garofolo F
    Bioanalysis; 2010 Aug; 2(8):1501-13. PubMed ID: 21083350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dried blood spot sampling for quantitative bioanalysis: time for a revolution?
    Spooner N
    Bioanalysis; 2010 Nov; 2(11):1781. PubMed ID: 21083481
    [No Abstract]   [Full Text] [Related]  

  • 11. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods.
    Abu-Rabie P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1373-84. PubMed ID: 21083338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds.
    Bowen CL; Hemberger MD; Kehler JR; Evans CA
    Bioanalysis; 2010 Nov; 2(11):1823-8. PubMed ID: 21083490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glowing future for dried blood spot sampling.
    Spooner N
    Bioanalysis; 2010 Aug; 2(8):1343-4. PubMed ID: 21083330
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of DBS technology for the detection of therapeutic antibodies.
    Prince PJ; Matsuda KC; Retter M; Scott G
    Bioanalysis; 2010 Aug; 2(8):1449-60. PubMed ID: 21083345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS.
    Kehler JR; Bowen CL; Boram SL; Evans CA
    Bioanalysis; 2010 Aug; 2(8):1461-8. PubMed ID: 21083346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating and defining sample preparation procedures for DBS LC-MS/MS assays.
    Liu G; Patrone L; Snapp HM; Batog A; Valentine J; Cosma G; Tymiak A; Ji QC; Arnold ME
    Bioanalysis; 2010 Aug; 2(8):1405-14. PubMed ID: 21083341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots.
    Heinig K; Bucheli F; Hartenbach R; Gajate-Perez A
    Bioanalysis; 2010 Aug; 2(8):1423-35. PubMed ID: 21083343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing efficiency for dried blood spot analysis: prospects for automation and simplified sample analysis.
    Wong P; Pham R; Bruenner BA; James CA
    Bioanalysis; 2010 Nov; 2(11):1787-9. PubMed ID: 21083483
    [No Abstract]   [Full Text] [Related]  

  • 19. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors.
    D'Arienzo CJ; Ji QC; Discenza L; Cornelius G; Hynes J; Cornelius L; Santella JB; Olah T
    Bioanalysis; 2010 Aug; 2(8):1415-22. PubMed ID: 21083342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic considerations as to when to use dried blood spot sampling.
    Emmons G; Rowland M
    Bioanalysis; 2010 Nov; 2(11):1791-6. PubMed ID: 21083484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.